Abstract
The goal in managing patients with Hodgkin’s disease is cure of the disease with minimal morbidity, yet maximal quality of life. This goal is universal; it does not represent a controversy. The issues over which there rest divided opinions relate to therapeutic orientation on how to achieve this goal and are largely issues of staging, treatment, and follow-up. Some controversies arise because of facilities available, individual expertise, or experience. Today a child with Hodgkin’s disease has an ~90% likelihood of cure following accurate staging and treatment in a center with demonstrated expertise in pediatric Hodgkin’s disease [1]. Such gratifying results require individualization of therapy, as no two cases of the disease are identical. The management of children requires utilization of not only principles that apply to the adult population, but also judgment with respect to age, stage, and extent of disease, tumor burden, therapeutic options, and late effects of treatment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Donaldson SS: Hodgkin’s disease. In: Voute PA, Barrett A, Bloom HJG, Lemerle J, Neidhardt MK (eds) Cancer in children: clinical management, 2nd edn. Berlin: Springer, 1986, pp 164–175.
Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M: Report of the Committee on Hodgkin’s Disease Staging. Cancer Res 31:1860–1861, 1971.
Musshoff K, Boutis L: Therapy results in Hodgkin’s disease. Freiburg i. Br., 1948–1966. Cancer 21:1100–1113, 1968.
Musshoff K: Therapy and prognosis of two different forms of organ involvement in cases of malignant lymphoma (Hodgkin’s disease, reticulum cell sarcoma, lymphosarcoma) as well as a report about stage division in these diseases. Klin Wochenschr 48:673–678, 1970.
Kaplan HS: Hodgkin’s disease, 2nd edn. Cambridge: Harvard University, 1980.
Levi JA, Wiernik PH: Limited extranodal Hodgkin’s disease: unfavorable prognoses and therapeutic implications. Am J Med 63:365–372, 1977.
Torti FM, Portlock CS, Rosenberg SA, Kaplan HS: Extralymphatic Hodgkin’s disease: prognosis and response to therapy. Am J Med 70:487–492, 1981.
Lee CKK, Bloomfield CD, Goldman AI, Nesbit ME, Levitt SH: The therapeutic utility of lung irradiation for Hodgkin’s disease patients with large mediastinal masses. Int J Radiat Oncol Biol Phys 7:151–154, 1981.
Hagemeister FB, Fuller LM, Velasquez WS, et al.: Stage I and II Hodgkin’s disease: involved-field radiotherapy versus extended-field radiotherapy versus involved-field radiotherapy followed by six cycles of MOPP. Cancer Treat Rep 66:789–798, 1982.
Hoppe RT, Coleman CN, Cox PS, Rosenberg SA, Kaplan HS: The management of stage I-II Hodgkin’s disease with irradiation alone or combined modality therapy: the Stanford experience. Blood 59:455–465, 1982.
Mauch P, Gorshein D, Cunningham J, Hellman S: Influence of mediastinal adenopathy on site and frequency of relapse in patients with Hodgkin’s disease. Cancer Treat Rep 66:809–818, 1982.
Thar TL, Million RR, Hausner RJ, McKetty MHB: Hodgkin’s disease, stage I and II: relationship of recurrence to size of disease, radiation dose, and number of sites involved. Cancer 43:1101–1105, 1979.
Velentjas E, Barrett A, McElwain TJ, Peckham MJ: Mediastinal involvement in early-stage Hodgkin’s disease: response to treatment and pattern of relapse. Eur J Cancer 16:1065–1068, 1980.
Castellino RA, Blank N, Hoppe RT, Cho C: Hodgkin’s disease: contributions of chest CT in the initial staging evaluation. Radiology 160:603–605, 1986.
Meyer JE, Linggood RM, Lindfors KK, McLoud TC, Stomper PC: Impact of thoracic computed tomography on radiation therapy planning in Hodgkin’s disease. J Comput Assist Tomogr 8:892–894, 1984.
Rostock RA, Siegelman SS, Lenhard RE, Wharam MD, Order SE: Thoracic CT scanning for mediastinal Hodgkin’s disease: results and therapeutic implications. Int J Radiat Oncol Biol Phys 9:1451–1457, 1983.
Robinson B, Kingston J, Nogueira Costa R, Malpas JS, Barrett A, McElwain TJ: Chemotherapy and irradiation in childhood Hodgkin’s disease. Arch Dis Child 59:1162–1167, 1984.
Bonadonna G, Valagussa P, Santoro A: Prognosis of bulky Hodgkin’s disease treated with chemotherapy alone or combined with radiotherapy. Cancer Surv 4:439–458, 1985.
Lister TA, Dorreen MS, Faux M, Jones AE, Wrigley PFM: The treatment of stage III-A Hodgkin’s disease. J Clin Oncol 1:745–749, 1983.
Prosnitz LR, Cooper D, Cox EB, Kapp DS, Farber LR: Treatment selection for stage III-A Hodgkin’s disease patients. Int J Radiat Oncol Biol Phys 11:1431–1437, 1985.
Desser RK, Golomb HM, Ultmann JE, et al.: Prognostic classification of Hodgkin’s disease in pathologic stage III based on anatomic considerations. Blood 49:883–893, 1977.
Hoppe RT, Rosenberg SA, Kaplan HS, Cox RS: Prognostic factors in pathological stage III-A Hodgkin’s disease. Cancer 46:1240–1246, 1980.
Hoppe RT, Cox RS, Rosenberg SA, Kaplan HS: Prognostic factors in pathologic stage III Hodgkin’s disease. Cancer Treat Rep 66:743–749, 1982.
Dunnick NR, Parker BR, Castellino RA: Pediatric lymphography: performance, interpretation and accuracy in 193 consecutive children. Am J Radiol 129:639–645, 1977.
Castellino RA, Bellani FF, Gasparini M, Terno G, Musumeci R: Lymphography in childhood: six years experience with 242 cases. Lymphology 8:74–83, 1975.
Daneman A, Martin DJ, Fitz CR, Chan HSL: Computed tomography and lymphogram correlation in children with Hodgkin’s disease. J Comput Assist Tomogr 7:115–122, 1983.
Castellino RA, Marglin SI: Imaging of abdominal and pelvic lymph nodes: lymphography or computed tomography? Invest Radiol 17:433–443, 1982.
Parker BR, Castellino RA, Kaplan HS: Pediatric Hodgkin’s disease. I. Radiographic evaluation. Cancer 37:2430–2435, 1976.
Castellino RA, Hoppe RT, Blank N, et al.: Computed tomography, lymphography, and Staging laparotomy: correlations in initial staging of Hodgkin’s disease. Am J Radiol 143:37–41, 1984.
Green DM, Ghoorah J, Douglass HO, et al.: Staging laparotomy with splenectomy in children and adolescents with Hodgkin’s disease. Cancer Treat Rev 10:23–38, 1983.
Wilimas J, Thompson E, Smith KL: Value of serum copper levels and erythrocyte sedimentation rates as indicators of disease activity in children with Hodgkin’s disease. Cancer 42:1929–1935, 1978.
Mauch P, Goodman R, Hellman S: The significance of mediastinal involvement in early stage Hodgkin’s disease. Cancer 42:1039–1045, 1978.
Schomberg PJ, Evans RG, O’Connell MJ, et al.: Prognostic significance of mediastinal mass in adult Hodgkin’s disease. Cancer 53:324–328, 1984.
Donaldson SS, Link MP: Combined modality treatment with low-dose radiation and MOPP chemotherapy for children with Hodgkin’s disease. 1987 (in press).
Ray GR, Trueblood HW, Enright LP, Kaplan HS, Nelsen TS: Oophoropexy: a means of preserving ovarian function following pelvic megavoltage radiotherapy for Hodgkin’s disease. Radiology 96:175–180, 1970.
Donaldson SS, Glatstein E, Rosenberg SA, Kaplan HS: Pediatric Hodgkin’s disease. II. Results of therapy. Cancer 37:2436–2447, 1976.
Botnick LE, Goodman R, Jaffe N, Filler R, Cassady JR: Stages I-III Hodgkin’s disease in children: results of staging and treatment. Cancer 39:599–603, 1977.
Dearth JC, Gilchrist GS, Burgert EO, Telander RL, Cupps RE: Management of stages I to III Hodgkin’s disease in children. J Pediatr 96:829–836, 1980.
Russell KR, Donaldson SS, Cox RS, Kaplan HS: Childhood Hodgkin’s disease: patterns of relapse. J Clin Oncol 2:80–87, 1984.
Boles ET, Haase GM, Hamoudi AB: Partial splenectomy in staging laparotomy for Hodgkin’s disease: an alternative approach. J Pediatr Surg 13:581–586, 1978.
Dearth JC, Gilchrist GS, Telander RL, O’Connell MJ, Weiland LH: Partial splenectomy for staging Hodgkin’s disease: risk of false-negative results. N Engl J Med 299:345–346, 1978.
Jereb B, Tan C, Bretsky S, He S, Exelby P: Involved field (IF) irradiation with or without chemotherapy in the management of children with Hodgkin’s disease. Med Pediatr Oncol 12:325–332, 1984.
Cramer P, Andrieu J: Hodgkin’s disease in childhood and adolescence: results of chemotherapy-radiotherapy in clinical stages IA-IIB. J Clin Oncol 3:1495–1502, 1985.
Bayle-Weisgerber C, Lemercier N, Teillet F, Asselain B, Gout M, Schweisguth O: Hodgkin’s disease in children: results of therapy in a mixed group of 178 clinical and pathologically staged patients over 13 years. Cancer 54:215–222, 1984.
Jenkin D, Chan H, Freedman M, et al.: Hodgkin’s disease in children: treatment results with MOPP and low-dose, extended-field irradiation. Cancer Treat Rep 66:949–959, 1982.
Andrieu J, Desprez-Curely J, Jacquillat C, Weil M: MOPP chemotherapy plus irradiation for Hodgkin’s disease, stage I-A to III-B: long-term results of the prospective trial H72 (1972–1976, 334 patients). Hematol Oncol 3:219–231, 1985.
Donaldson SS, Kaplan HS: Complications of treatment of Hodgkin’s disease in children. Cancer Treat Rep 66:977–989, 1982.
Desser RK, Ultmann JE: Risk of severe infection in patients with Hodgkin’s disease or lymphoma after diagnostic laparotomy and splenectomy. Ann Intern Med 77:143–146, 1972.
Rosenstock JG, D’Angio GJ, Kiesewetter WB: The incidence of complications following staging laparotomy for Hodgkin’s disease in children. Radiology 120:531–535, 1974.
Chilcote RR, Baehner RL, Hammond D, and Children’s Cancer Study Group: Septicemia and meningitis in children splenectomized for Hodgkin’s disease. N Engl J Med 295:798–800, 1976.
Donaldson SS, Glatstein E, Vosti KL: Bacterial infections in pediatric Hodgkin’s disease: relationship to radiotherapy, chemotherapy and splenectomy. Cancer 41:1949–1958, 1978.
Weitzman S, Aisenberg AC: Fulminant sepsis after the successful treatment of Hodgkin’s disease. Am J Med 62:47–50, 1977.
Dailey MO, Coleman CN, Kaplan HS: Radiation-induced splenic atrophy in patients with Hodgkin’s disease and non-Hodgkin’s lymphomas. N Engl J Med 302:215–217, 1980.
Coleman CN, McDougall IR, Dailey MO, Ager P, Bush S, Kaplan HS: Functional hyposplenia after splenic irradiation for Hodgkin’s disease. Ann Intern Med 96:44–47, 1982.
Siber GR, Weitzman SA, Aisenberg AC, Weinstein HJ, Schiffman G: Impaired antibody response to pneumococcal vaccine after treatment for Hodgkin’s disease. N Engl J Med 299:442–448, 1978.
Donaldson SS, Vosti KL, Berberich FR, Cox RS, Kaplan HS, Schiffman G: Response to pneumococcal vaccine among children with Hodgkin’s disease. Rev Infect Dis [Suppl] 3:S133-S143, 1981.
Russell KJ, Hoppe RT, Colby TV, Burns BF, Cox RS, Kaplan HS: Lymphocyte predominant Hodgkin’s disease: clinical presentation and results of treatment. Radiother Oncol 1:197–205, 1984.
Jacobs P, King HS, Karabus C, Hartley P, Werner D: Hodgkin’s disease in children: a ten-year experience in South Africa. Cancer 53:210–213, 1984.
Ekert H, Waters KD: Results of treatment of 18 children with MOPP chemotherapy as the only treatment modality. Med Pediatr Oncol 11:322–326, 1983.
Olweny CLM, Katongole-Mbidde E, Kiire C, Lwanga SK, Magrath I, Ziegler JL: Childhood Hodgkin’s disease in Uganda: a ten-year experience. Cancer 42:787–792, 1978.
Probert JC, Parker BR, Kaplan HS: Growth retardation in children after megavoltage irradiation of the spine. Cancer 32:634–639, 1973.
Kaplan HS, Rosenberg SA: The treatment of Hodgkin’s disease. Med Clin North Am 50:1591–1610, 1966.
De Vita VT, Serpick AA, Carbone PP: Combination chemotherapy in the treatment of advanced Hodgkin’s disease. Ann Intern Med 73:881–895, 1970.
Bonadonna G, Zucali R, Monfardini S, De Lena M, Uslenghi C: Combination chemotherapy of Hodgkin’s disease with adriamycin, bleomycin, vinblastine and imadazole carbox-amide versus MOPP. Cancer 36:252–259, 1975.
Valagussa P, Santoro A, Fossati Bellani F, Franchi F, Banfi A, Bonadonna G: Absence of treatment-induced second neoplasms after ABVD in Hodgkin’s disease. Blood 59:488–494, 1982.
Mauch PM, Weinstein H, Botnick L, Belli J, Cassady JR: An evaluation of long-term survival and treatment complications in children with Hodgkin’s disease. Cancer 51:925–932, 1983.
Wilimas J, Thompson E, Smith KL: Long-term results of treatment of children and adolescents with Hodgkin’s disease. Cancer 46:2123–2125, 1980.
Herman TS, Hoppe RT, Donaldson SS, Cox RS, Rosenberg SA, Kaplan HS: Late relapse among patients treated for Hodgkin’s disease. Ann Intern Med 102:292–297, 1985.
Constine LS, Donaldson SS, McDougall IR, Cox RS, Link MP, Kaplan HS: Thyroid dysfunction after radiotherapy in children with Hodgkin’s disease. Cancer 53:878–883, 1984.
McDougall IR, Coleman CN, Burke JS, Saunders W, Kaplan HS: Thyroid carcinoma after high-dose external radiotherapy for Hodgkin’s disease: report of three cases. Cancer 45: 2056–2060, 1980.
Jochelson M, Mauch P, Balikian J, Rosenthal D, Canellos G: The significance of the residual mediastinal mass in treated Hodgkin’s disease. J Clin Oncol 3:637–640, 1985.
Jochelson MS, Tarbeil NJ, Weinstein HJ: Unusual thoracic radiologic findings in children treated for Hodgkin’s disease. J Clin Oncol 4:874–882, 1986.
Castellino RA, Bergiron C, Markovits P: Repeat lymphography in children with Hodgkin’s disease. Cancer 38:90–95, 1976.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Kluwer Academic Publishers, Boston
About this chapter
Cite this chapter
Donaldson, S.S. (1989). Current management and controversies. In: Kamps, W.A., Humphrey, G.B., Poppema, S. (eds) Hodgkin’s Disease in Children. Cancer Treatment and Research, vol 41. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1739-5_11
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1739-5_11
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8978-4
Online ISBN: 978-1-4613-1739-5
eBook Packages: Springer Book Archive